Drew Fallon argues GLP-1 drugs are still underrated despite all the attention
Fallon says semaglutide and tirzepatide pull in about 60% of the combined run rate revenue of Anthropic and OpenAI, at a sixth of the reach.
Recap by typeshit. Post by Drew Fallon on X.